soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Presented at ACC.25: Among participants with type 2 diabetes and disease, chronic kidney disease, or both, (14 mg) was associated with a lower risk of cardiovascular events than placebo In patients with cardiometabolic #HFpEF,

[DOI] [PubMed] [Google Scholar] 67.Manczak M., Calkins M

Mistake 4: Injecting into muscle If the needle enters muscle tissue instead of subcutaneous fat, the medication absorbs differently and the injection hurts significantly more

For more detail about the 2021 survey, see the Survey Methodology section of that years report

In the galactose-induced model, hyperglycemia resulting from galactose overload activates the polyol pathway, leading to the accumulation of galactitol within the lens and subsequent osmotic swelling

The recommendations are still in draft form and could change following input from an open consultation